Wereport a 42-year-old Japanese womanwith Recklinghausen's neurofibromatosis 1 (NF1) who developed mixed connective tissue disease (MCTD). Previously experiencing good health without an increase in subcutaneous nodules, she presented with Raynaud's phenomenon, swollen hands and polyarthralgia. Clinical examination revealed a high titer of anti-RNP antibody, and she was thus diagnosed as having MCTD. She was treated with oral prednisolone (10 mg/day) and her symptoms improved rapidly.
Introduction
Mixed connective tissue disease (MCTD)is a distinct entity of autoimmunediseases and is characterized by overlapping systemic lupus erythematosus (SLE), systemic sclerosis (SSc), polymyositis /dematomyositis (PM/DM),and the presence of high-titer of specific antibody, anti-UlRNP (1). Von
Recklinghausen's neurofibromatosis 1 (NF1) is one of the common autosomal dominant diseases in humans, with an incidence of 1 in 2,500-3,300 (2) . Wereport a female patient with MCTD in association with von Recklinghausen's neurofibromatosis. To date, such an association has not been previously reported.
Case Report
A 42-year-old womanwas referred to our department on March 13, 1997, for Raynaud's phenomenon. Since her twenties, she had noticed small skin nodules with pigmented lesions over her body. The skin nodules on her back had increased to the size of0.5-1 cm by the time she was 40. Six months prior to her visit to our department, she had experienced generalized arthralgia, hair loss, swollen hands and Raynaud's phenomenon.
On physical examination, her height was measured at 154 cm and body weight was 44 kg. She was afebril and her BP was 120/70 mmHg.Her oral mucous membrane was not dry. There were no abnormal findings in her chest and abdomen. Her extremities were cyanotic and cold. She had sclerodactyly as well as swollen hands. Her metacarpophalangeal (MP) joints of both fingers were swollen. Skin examination revealed cafe au lait spots and subcutaneous nodules ( Fig. 1 , 0.5-1 cm in diameter) on her trunk. She was thus diagnosed as having von Recklinghausen's neurofibromatosis (NF1 ).
The laboratory findings were as follows. There was no abnormality in urinalysis. Complete blood cell count demonstrated mild anemia (Hg 10.4 g/dl), but neither leukocytopenia nor thrombocytopenia was noted. Blood chemistry analysis showed her liver, kidney functions, and muscle enzymes to be normal. Serological tests revealed some autoantibodies. Rheumatoid factor was negative. Anti-nuclear antibody (ANA) was positive at a titer of 1: 2,560 with speckled pattern. Although the anti-DNAAb (RIA) was at borderline levels ( 12.4 IU/ml; <7.0), her serum level of complement (CH50) was normal (53 U/ml). Antibody to extractable nuclear antigen for U l -RNPwas positive with a titer >256X, but those for Smand Scl-70 were negative. Serum immunecomplex was not detected. Serologic HLA Class I (A, B and C) and Class II (DR) typing was HLAA2 A31;B35B62;Cw3;DR2DR8.
X-ray analysis of hands showed no abnormalities of the joints.
The diagnosis of MCTDwas made according to the diagno- sis criteria by Japan Ministry of Health and Welfare (3). She was administered prednisolone ( 10 mg/day) plus beraprost sodium (40 (ig/day) orally, after which her symptoms were improved.
Discussion
Mixed connective tissue disease (MCTD)was originally described as a syndromethat consists of a combination of features found in systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and polymyositis/dermatomyositis (PM/DM) with a high-titer of anti-UlnRNP antibody (1 , 4) . Controversy has continued regarding about whether MCTD is a distinct entity (undifferentiated) or an overlap syndrome differentiated into either SLE, SSc, or RA (5, 6) . In this patient, clinical manifestations compatible with SLE, SSc, and PM/DM were not seen and she met none of the ACRcriteria for individual disease. On the other hand, NF1 is the most commonform and presents mainly peripheral involvement: cafe-au-lait spots, skeletal involvement, and cutaneous neurofibromas (2). As described in our patient's history, signs of neurofibromatosis are more evident after puberty. The pathogenesis by which MCTD is associated with NF1 is unknown. Gerosa et al (7) investigated the immunological parameters such as complement, antiDNAantibodies, and immune complex (IC) in patients with NFLInterestingly, the data showed borderline levels of antiDNAAb and IC in some patients. The association of autoimmunediseases such as membranous glomerulonephritis and RAhas been demonstrated in NF1 (8) (9) (10) . Also, the association ofNF1 in SLEwas reported in 3 cases (ll, 12) . However, the association of MCTD has not been demonstrated in NF1 up to the present time. Associations between certain HLAtypes and MCTDhave been reported by several investigators (3). Gendi et al ( 13) demonstrated that non-differentiated MCTD is associated with HLA-DR2or DR4. This genetic factor (HLA-DR2)maycontribute to the occurrence of MCTD in the present patient. Alternatively, MCTDmanifesting in the presence of NF1 may be coincidental. The details of the relationship between these two diseases are unknown.
In conclusion, this is the first case report demonstrating an association between MCTDand von Recklinghausen's neurofibromatosis, also raising the question as to whythis association has not been seen moreoften.
